Orion Biotech Opportunities - Warrants (15/04/2025) Operating Income

As of the most recent data (December 2022), ORIAW shows a operating income of $-900K. That compares with $-630K in the prior-year period — down 43.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ORIAW's operating income is now $-900K (was $-630K) — a 43.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Orion Biotech Opportunities - Warrants (15/04/2025) is outperforming or lagging.

Tracking ORIAW's operating income over time shows whether Orion Biotech Opportunities - Warrants (15/04/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $-900K That compares with $-630K in the prior-year period — down 43.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Orion Biotech Opportunities - Warrants (15/04/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-900K) with ownership activity and broader fundamentals.